EU’s only cultivated GM crop, insect-resistant Bt corn, poses no risk to humans or the environment, study finds

corn

Following a request from the European Commission, the EFSA assessed the 2018 post‐market environmental monitoring (PMEM) report on the cultivation of Cry1Ab‐expressing maize event MON 810 [insect-resistant Bt corn]. Like previous years, there was partial compliance with refuge requirements by Spanish farmers growing MON 810 varieties. European and Mediterranean corn borer populations collected from north‐eastern Spain during the 2018 maize growing season and tested for Cry1Ab susceptibility show no symptoms of resistance to maize MON 810.

The evidence from the 2018 PMEM report and the additional information provided by the consent holder upon EFSA’s request does not indicate any adverse effects on human and animal health or the environment arising from the cultivation of maize MON 810 during the 2018 growing season. Consequently, previous evaluations on the safety of maize MON 810 (EFSA, 2009; EFSA GMO Panel, 2012b,c) remain valid.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

EFSA believes that a robust and fit‐for‐purpose farmer alert system may help to detect unexpected adverse effects caused by the cultivation of maize MON 810 and be an alternative to the current farmer survey system. EFSA recommends all stakeholders, including EU Member States and relevant national Competent Authorities, to have a dialogue and agree on how farmers growing maize MON 810 could best identify and report unexpected adverse effects from the cultivation of Bt maize varieties and on how to take stock of existing environmental networks.

In the meantime, EFSA is of the opinion that farmer questionnaires should remain in place and that their implementation should integrate the above‐mentioned recommendations to improve their efficiency and potential to detect unexpected adverse effects.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Aug-4-2026-10_15_14-AM
Viewpoint—A hard look at the Fauci diaries: Do they change what we know about COVID’s origins?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Aug-4-2026-12_42_58-PM
Viewpoint: Fact-checking CNN interview with RFK, Jr. underscores the depth of his disinformation delusions
Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT-Image-Jul-17-2026-09_50_27-AM
Viewpoint: How disease tracking and prevention has cratered under the Kennedy-Trump administration
ChatGPT-Image-Aug-4-2026-07_52_00-PM
No liability for scientific due diligence: California Supreme Court rejects bizarre lawsuit faulting Gilead for fully evaluating HIV drug before release
ChatGPT-Image-Aug-4-2026-09_31_50-AM-2
Viewpoint: Could the U.S. become dependent on China to develop critical new genetic and drug therapies?
ChatGPT-Image-Aug-4-2026-02_05_46-PM
Does Congress have the guts to successfully challenge Trump’s politicization of science funding?
png livestock cow cattle a
Consumer skepticism about gene-edited milk is neither fixed nor particularly high—and falls even more if it’s priced lower
Screenshot-2026-07-17-at-1.34.59-PM
Poll: Vaccine hesitancy soars when patients distrust health providers and turn to social media
ChatGPT Image Jul 29, 2026, 09_08_15 AM 2
The retreat of environmental extremism: Why activist NGOs are losing favor
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.